Thermo Fisher's sweetened Qiagen bid fails to win over key investor | Reuters
Thermo Fisher, QIAGEN Part Ways as COVID-19 Fuels Collapse of $12.5B Deal
How COVID-19 Testing Demand Threw off Thermo Fisher's Acquisition of Qiagen – Health Advances Blog
BREAKING: Thermo Fisher drops bid for Qiagen - Drug Delivery Business
Thermo Fisher Scientific Amends its Agreement to Acquire QIAGEN
Thermo Fisher Scientific Inc. - Investors
Qiagen chairman quits after Thermo Fisher's takeover bid fails | Reuters.com
Thermo Fisher Scientific to Acquire QIAGEN N.V.
Thermo Fisher Scientific Set to Acquire Qiagen for $11.5B | mddionline.com
Thermo Fisher Scientific to acquire QIAGEN for $11.5bn
Thermo Fisher increases takeover price for Qiagen by $1bn
Thermo Fisher Scientific to Acquire QIAGEN N.V.
Thermo Fisher May Need to Boost Qiagen Bid Again, Investor Says - Bloomberg
Thermo Fisher Expands Diagnostics Capabilities with $11.5 Billion Takeover of Qiagen | BioSpace
Thermo Fisher Scientific to Acquire Qiagen | CHEManager
Deals News: Thermo Fisher Scientific to Buy Qiagen for $12 Bln - Bloomberg
Top Tier Firms Advise on Thermo Fisher's $11.5 Billion Acquisition of Qiagen | Law.com International
Thermo Fisher's $12.5B deal for Qiagen falls through, as COVID-19 test demand lights new path forward | Fierce Biotech
How COVID-19 Testing Demand Threw off Thermo Fisher's Acquisition of Qiagen – Health Advances Blog
Webinar: Manufacturers of COVID-19 Molecular Diagnostic Tests: Qiagen and Thermofisher Scientific – Africa CDC
Thermo Fisher Is Buying Qiagen for $11.5 Billion. It's a 'Home Run' Deal. | Barron's
Why did the Thermo Fisher-Qiagen deal fall apart?
